In NASH (non-alcoholic steatohepatitis), there is a predominance of pro-inflammatory LOX and non-enzymatic products, along with reduced availability of precursors, which indicates metabolic dysregulation and susceptibility to inflammatory reactions and fibrosis [65]. This evidence concerns the gene LOX and metabolic dysfunction-associated steatohepatitis.